参考资料 [1]Del Bufalo F,et al.GD2-CART01 for relapsed or refractory high-risk neuroblastoma[J]. New England Journal of Medicine, 2023, 388(14): 1284-1295.https://www.nejm.org/doi/full/10.1056/NEJMoa2210859
参考资料 [1]Del Bufalo F,et al.GD2-CART01 for relapsed or refractory high-risk neuroblastoma[J]. New England Journal of Medicine, 2023, 388(14): 1284-1295. https://www.nejm.org/doi/full/10.1056/NEJMoa2210859
①The New England Journal of Medicine:GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma临床研究:自体第三代GD2-CAR T细胞(GD2-CART01)用于复发或难治性高危神经母细胞瘤Nature Reviews DOI :10.1056/NEJMoa2210859②Science Immunology:Identification of a broadly f...